your personal
category
|
risk
statement
|
average lifetime risk...no known
current breast problem
|
11% (1 in 9); see introductory
paragraph, above
|
average lifetime
risk ...no known current breast problem, but has previously had an
induced abortion
|
(50% risk increase) 17% (1.5 in
9); see introductory paragraph, above; see web site [here]
|
started
her periods before age 14
|
1.1-1.9 x the lifetime risk of those
starting after age 14
|
menopause, from any reason, before age
45
|
half the lifetime risk...5.5 % (1 in
18)
|
menopausal and still has dense bones (not
osteoporotic)
|
3x the lifetime risk of those with all
else similar except that they show bone thinning
|
risk
for an average North American women getting breast cancer between her 40th
and 41st birthday
|
1 in 1000 (0.1 %) 12 month
risk
|
risk for an average North American women
getting breast cancer between her 20th and 40th
birthday
|
5 in 1000 (0.49%) specific
20-year-interval risk
|
risk
for an average North American women getting breast cancer between her 35th
and 55th birthday
|
5 in 200 (2.53%) specific
20-year-interval risk
|
risk for an average North American women
getting breast cancer between her 50th and 70th
birthday
|
4.67 in
100 (4.67%) specific 20-year-interval
risk
|
risk
for an average North American women getting breast cancer between her 65th
and 85th birthday
|
5.48 in 100 (5.48%) specific
20-year-interval risk
|
if ONE
blood kin of: your mother, a sister, or a daughter has breast cancer in one
breast prior to menopause
|
33-44% lifetime risk for you to get
breast cancer (3-4 out of every 9 such
women)
|
if one
blood kin of : your mother, a sister, or a daughter has breast cancer in both
breasts prior to menopause; OR, if TWO or MORE of these kin have a breast
cancer before menopause
|
80-90% lifetime risk for you to get breast
cancer
(8-9 out of every 10 such
women)
|
if you
get regular breast exams and mammograms, sooner or later a suspicious area
will show up which must be biopsied by one of the many procedure
choices
|
at least 20% chance of having a biopsy
by age 85 (mostly age 40-85)
|
if
biopsy [all biopsy types] is because of a suspicious
mammogram*
|
up to 50% risk per each surgery that
the biopsy will diagnose cancer
|
if a
LCNB type of biopsy is because of a suspicious
mammogram*
|
up to 24% risk per each surgery that
the biopsy will diagnose cancer; but 30% of that 24% will be "non-invasive"
cancer
|
if
biopsy is because someone (clinically) detects a suspicious
lump
|
up to 25% risk per each surgery that
the biopsy will diagnose cancer
|
if
mammographically dense breasts
|
3x the average risk at that age
group
|
cancer
finding
|
65% are found by
mammograms
(when smallest and most likely completely
curable)
|
of
invasive cancers detected by mammogram
|
86% are later proven to have negative
lymph nodes
|
if our
pathology report diagnosis is one of the benign, "non-proliferative" breast
diseases
|
no increased future risk
identified
|
if our pathology
report diagnosis is benign but "proliferative" breast disease:
1. papilloma with fibrovascular core
2. moderate-to-florid
hyperplasia
|
an average person's lifetime risk
jumps up by a factor of 1.5x to 2x
|
if our pathology
report diagnosis is benign
atypical ductal hyperplasia
(ADH)**
|
diagnosis category
serves as a
precancerous warning marker of a 4x to 5x increased
lifetime risk of cancer developing at the same biopsy site or in some other site in
either breast in an average person
|
if our pathology
report diagnosis is benign
atypical lobular hyperplasia
(ALH)***
|
diagnosis category serves as
a
precancerous warning marker of a 4x to 5x increased
lifetime risk of cancer developing at the same biopsy site or in some other site in
either breast in an average person
|
if our pathology
report diagnosis is
"non-comedo" ductal carcinoma-in-situ
(d-CIS)**
|
the 9x to 11x increased lifetime
future recurrence risk will be at the same site in the same
breast
|
if our pathology
report diagnosis is
lobular carcinoma-in-situ
(l-CIS)***
|
diagnosis category
serves as a
precancerous warning marker of a 7x to 12x increased
lifetime risk of cancer developing at the same biopsy site or in some other site in
either breast in an average person
|
if our pathology
report diagnosis is
"comedo" ductal carcinoma-in-situ
(d-CIS)**
|
the increased lifetime future
recurrence risk is very high, greater than 12x, and will be at the same site
in the same breast in an average person
|